#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial amyotrophic lateral sclerosis Colitis ulcerative Primary adrenal insufficiency Langerhans' cell histiocytosis Tourette's disorder Uterine leiomyosarcoma Laryngeal squamous cell carcinoma Central nervous system neoplasm Palmar-plantar erythrodysaesthesia syndrome Sickle cell anaemia CDKL5 deficiency disorder Angiosarcoma recurrent Endometrial cancer recurrent Epilepsy Hormone-dependent prostate cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Trials in Disease Immunodeficiency congenital – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Combined immunodeficiency – Basic Information Andersen-Tawil syndrome – Life with Disease Adrenocortical carcinoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Basal cell naevus syndrome – Diagnostics VEXAS syndrome – Trials in Disease SAPHO syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Thiosulfate Gallium Citrate Ga-68 Nms-03305293 Propafenone Hydrochloride Bimekizumab Fosfomycin Trometamol Sacubitril GLYCYL-TYROSINE OMECAMTIV MECARBIL Ethambutol AZD0120 Bgb-A445 TRIMIPRAMINE MALEATE COLESEVELAM HYDROCHLORIDE RIMIDUCID Selatogrel Rgx-202 Zongertinib ANGIOTENSIN II INF904 More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis I Cervix carcinoma Testicular leiomyosarcoma Hairy cell leukaemia recurrent Osteoporosis HER2 positive breast cancer Epithelioid sarcoma Hypopituitarism Migraine Adenocarcinoma Weaning failure Dementia with Lewy bodies Mitochondrial DNA depletion Body mass index increased Malignant fibrous histiocytoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Clobetasol Propionate and Prednisolone Acetate for Treating Eye Inflammation After Cataract Surgery in Children Aged 0-3 Years

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Eye inflammation
    • Eye pain
    Investigated Drugs:
    • Clobetasol Propionate
    • Prednisolone Acetate
    Spain

  • Study Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Fluocinolone Acetonide
    • Dexamethasone
    France

  • Study Comparing Adalimumab and Mycophenolate Mofetil for Patients with Steroid-Dependent Non-Infectious Uveitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveitis
    Investigated Drugs:
    • Isoniazid
    • Indocyanine Green
    • Rifampicin
    France

  • Study on the Effectiveness of Somatostatin Eye Drops for Patients with Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy

    Recruiting

    4 1
    Investigated Diseases:
    • Diabetic retinopathy
    Investigated Drugs:
    • Somatostatin
    Spain

  • Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Alteplase
    Germany Ireland The Netherlands Poland Spain

  • Study on Ciclosporin for Treating Atopic Keratoconjunctivitis in Adults

    Recruiting

    2 1 1
    Investigated Diseases:
    • Atopic keratoconjunctivitis
    Investigated Drugs:
    • Ciclosporin
    Denmark
Previous Page
1 … 9 10 11 12 13 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!